A phase II trial evaluating liposomal irinotecan combined with capecitabine as second-line therapy for biliary tract cancer.
Alpha-fetoprotein-producing gastrointestinal malignancies represent a rare and aggressive subset of tumours chiefly arising in the stomach and, less commonly, the oesophagus or other segments of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results